PP17 Neuroendocrinology

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Neuroendocrinology and Pituitary-Clinical
Saturday, April 2, 2016: 11:30 AM-11:45 AM
Room 258 (BCEC)
Chairs:
To Be Determined and Tony M. Plant, Ph.D., University of Pittsburgh School of Medicine and Magee Womens Research Institute, Pittsburgh, PA

Nothing to Disclose: UBK, TMP Disclosure Not Provided: PEM
Daniel S Olsson, MD, PhD1, Anna G Nilsson, MD, PhD1, Oskar Ragnarsson, MD, PhD1, Ing-Liss Bryngelsson2, Eva Andersson, MD, PhD3, Michael Buchfelder, MD PhD4 and Gudmundur Johannsson, MD, PhD1, (1)Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
(2)Department of Occupational and Environmental Medicine, Örebro University Hospital, Örebro, Sweden
(3)Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
(4)Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany
Poster Board Number: SAT 478
Laura E. Dichtel, MD, MHS1, Elizabeth A. Lawson, MD, MMSc1, Erinne Meenaghan, NP2, Margaret Lederfine Paskal2, Kamryn T. Eddy, PhD3, Graziano Pinna, PhD4, Marianela Nelson4, Ann M. Rasmusson, MD5, Anne Klibanski, MD1 and Karen K. Miller, MD1, (1)Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA
(2)Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA
(3)Eating Disorders Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA
(4)Department of Psychiatry, University of Illinois, Chicago, IL
(5)National Center for PTSD, Department of Veterans Affairs, VA Boston Healthcare System, and Department of Psychiatry, Boston University School of Medicine, Boston, MA
Poster Board Number: SAT 479
Yuliya Afinogenova, MD1, Cindy B. Schmelkin, BS1, Franziska Plessow, PhD1, Jennifer J. Thomas, PhD2, Reitumetse L. Pulumo1, Nadia Micali, MD, PhD3, Karen K. Miller, MD1, Kamryn T. Eddy, PhD2 and Elizabeth A. Lawson, MD, MMSc1, (1)Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA
(2)Eating Disorders Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, MA
(3)Department of Psychiatry and Behavioural and Brain Sciences Unit, Icahn Medical School at Mount Sinai and UCL Institute of Child Health London, New York, NY
Poster Board Number: SAT 493
Susmeeta T. Sharma, M.D.1, Corina M Millo, MD2, Clara C Chen, MD3, Millie Whatley3, Ahmed M. Gharib, M.B., Ch.B.4, Raven N. McGlotten, M.S.N., R.N.1 and Lynnette K. Nieman, M.D.1, (1)PRAE, NICHD, NIH
(2)Positron Emission Tomography Department, NIH -Clinical Center, Bethesda, MD
(3)Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD
(4)NIDDK, NIH
Poster Board Number: SAT 495

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire